Literature DB >> 6120841

Combination therapy in hypertension. A population-based study in eastern Finland.

H Enlund, H Turakka, J Tuomilehto.   

Abstract

In a cross-sectional study, antihypertensive drug treatment was studied in a representative population sample of people aged 30-64 years, using a combination of postal survey, personal interview, clinical assessment and drug prescriptions. 11% of the men and 16% of the women were currently taking antihypertensives; 54% of patients used one, 38% used two, and 8% used three or more preparations. Men used slightly more drugs than women. Diuretics were used by 62% and betablockers by 49% of the sample population. Fixed combinations of thiazides and potassium-sparing agents formed 70% of all diuretic preparations used. Only 12% of the patients used fixed antihypertensive combinations, of which over half were diuretic-reserpine-vasodilator combinations; women and older patients used them most often. The most common freely combined preparations were diuretics and betablockers, which formed almost half of all two-drug combinations, and were also present in 70% of all triple combinations. Adequate control of blood pressure (DBP less than 100 mmHg) was achieved by slightly under 50% of the patients, the BP of women being more adequately controlled than that of men. Differences in BP control were found between the different drugs and combinations. Antihypertensive combination therapy is important in successful treatment, but we still cannot be sure whether fixed combination preparations or, as in this study, free combinations of marketed preparations are better alternatives for treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6120841     DOI: 10.1007/bf00609580

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

Review 1.  Pharmacological basis for combination therapy of hypertension.

Authors:  C T Dolley
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  ALPHA-METHYLDOPA AND HYDROCHLOROTHIAZIDE. A CONTROLLED STUDY OF THEIR COMPARATIVE EFFECTIVENESS AS ANTIHYPERTENSIVE AGENTS.

Authors:  J M COLWILL; A M DUTTON; J MORRISSEY; P N YU
Journal:  N Engl J Med       Date:  1964-10-01       Impact factor: 91.245

3.  Deviation from prescribed drug treatment after discharge from hospital.

Authors:  D M Parkin; C R Henney; J Quirk; J Crooks
Journal:  Br Med J       Date:  1976-09-18

4.  Effect of alprenolol and alprenolol in combination with saluretics in hypertension.

Authors:  G Angervall; U Bystedt
Journal:  Acta Med Scand Suppl       Date:  1974

5.  Editorial: Single daily dose of antidepressants.

Authors:  F J Ayd
Journal:  JAMA       Date:  1974-10-14       Impact factor: 56.272

6.  Hypertension--a community problem.

Authors:  J A Wilber; J G Barrow
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

7.  Community programme for control of hypertension in North Karelia, Finland.

Authors:  J Tuomilehto; A Nissinen; J T Salonen; T E Kottke; P Puska
Journal:  Lancet       Date:  1980-10-25       Impact factor: 79.321

8.  Report of a workshop on fixed-ratio drug combinations.

Authors:  H J Dengler; L Lasagna
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

9.  Coronary heart-disease after treatment of hypertension.

Authors:  G Berglund; R Sannerstedt; O Andersson; H Wedel; L Wilhelmsen; L Hansson; R Sivertsson; J Wikstrand
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

10.  Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project).

Authors:  P Puska; J Tuomilehto; J Salonen; L Neittaanmäki; J Maki; J Virtamo; A Nissinen; K Koskela; T Takalo
Journal:  Br Med J       Date:  1979-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.